For those individuals who, like myself, suffer from intense migraine headaches, the news today from the maker of Excedrin was not good. GlaxoSmithKline, the pharmaceutical manufacturer of the headache medicine, announced today that it would be temporarily removing both Excedrin Extra Strength and Excedrin Migraine, both in the form of caplets and gel-tablets, from market shelves.
Talk about one major headache!
The reason for the recall of the pain relievers, as well as the suspension of their production, was stated as irregularities having been found at the plants that make and produce the drugs. In a statement issued by the pharmaceutical company: "Through routine quality control and assurance measures, we discovered inconsistencies in how we transfer and weigh ingredients for Excedrin Extra Strength caplets and Geltabs and Excedrin Migraine Caplets and Geltabs.”
The company went on to say that the product does not present any type of risk to the safety of consumers based on data currently available to GSK. However, wanting to err on the side of caution, GSK has implemented voluntary discontinuation of both the production and the distribution of the pain meds.
Consumers, not having known of the recalls and discontinuation of production, arrived at stores only to find signs apologizing for any inconvenience taped to the empty shelves where the Excedrin boxes previously were. However, for those of us that are sufferers of severe migraine headaches and depend on Excedrin to aid in remaining functional, there will be more than an inconvenience in the days and weeks to come.
Many customers, again, such as myself, have tried different brands, but have found that the only brand to even begin to touch or take the edge off the pain is Excedrin. For those very same people, in most cases, their bodies will not accept any type of substitutes, and as such, the thought of being without the product is beyond more than a little scary to think about.
GSK was quick to note that their other Excedrin products are still currently on the shelves, those of which include Tension Headache, and PM Headache. They also emphasized that the issue is in no way related to any type of contamination, and the stop in production is only temporary.
The pharmaceutical company also emphasized that there is no danger in the use of the products, and if there were to be any type of affect, it would be reflected in the dosage taken. As such, no warning or indications were suggesting that the medication be discarded or thrown away.
Are the users of Excedrin getting the full truth from GSK?